Currently, Chinese Society of Clinical Oncology include CEA and CA19-9 measurements in the Class II recommendation for the staging and prognostic stratification of colonoscopy-diagnosed CRC patients [7]. Here, CEACAM5 is linked to colorectal carcinoma.